Hana Biosciences
San Francisco
About Hana Biosciences
Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company's lead product candidate, Marqibo(R), potentially treats acute lymphoblastic leukemia and lymphomas.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $116.3M
- Funding stage: Private Equity
- Last round: Private Equity (Jun 2010)
- Website: hanabiosciences.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hana-biosciences-2069377 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.